Exor N.V. (LON:0RKY)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 12.27B -21.9% |
| Revenue (ttm) | -3.07B |
| Net Income | -3.31B |
| EPS | -16.12 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.43 (0.70%) |
| Ex-Dividend Date | May 25, 2026 |
| Volume | 7,680 |
| Open | 70.30 |
| Previous Close | 70.28 |
| Day's Range | 70.18 - 71.60 |
| 52-Week Range | 59.85 - 97.35 |
| Beta | 0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 22, 2026 |
About Exor N.V.
Exor N.V. engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally. The company designs, engineers, produces, and sells luxury performance sports cars under the Ferrari brand. It also provides automotive vehicles and mobility solutions under the Abarth, Alfa Romeo, Chrysler, Citroen, Dodge, DS, Fiat, Fiat Professional, Jeep, Lancia, Maserati, Mopar, Opel, Peugeot, Ram, and Vauxhall brands; diagnostic imaging, ultrasound, ... [Read more]
News
Royal Philips And Exor Update Long-Term Relationship Agreement
(RTTNews) - Royal Philips (PHG), a health technology company, and Exor N.V., an investment company, announced that they have agreed to update their long-term relationship agreement.
Agnelli family's Exor can raise Philips stake to 22% under updated agreement
Philips' largest shareholder Exor , the investment arm of Italy's Agnelli family, has extended its agreement with the health technology firm, giving it the flexibility to increase its stake to up to 2...
Exor and Philips Extend Long-term Relationship Agreement
August 11, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Exor N.V. today announced that they have agreed to update their long-term r...
Exor Press Release - Leadership Changes
Amsterdam, 18 June 2026 EXOR ANNOUNCES LEADERSHIP CHANGES Exor N.V. (“Exor” or the “Company”) announces that Benoît Ribadeau-Dumas has been appointed Deputy Chief Executive Officer, effective 1 July 2...
Exor Press Release - 2026 AGM
Amsterdam, 20 May 2026 EXOR SHAREHOLDERS APPROVE ALL AGM RESOLUTIONS Exor N.V. (“Exor” or the “Company”) shareholders approved all resolutions proposed by the Board of Directors at the Annual Genera...
Exor Press Release - Png and Della Chiesa Nominations
Amsterdam, 8 April 2026 EXOR NOMINATES TEMASEK CFO PNG CHIN YEE AND BENEDETTO DELLA CHIESA TO ITS BOARD Exor nominates Png Chin Yee and Benedetto Della Chiesa as non-executive members of its Board o...
Exor N.V. Earnings Call Transcript: H2 2025
2025 saw a decline in NAV per share due to underperformance in key holdings, but strong results from Lingotto and major disposals strengthened liquidity. The focus for 2026 is on portfolio simplification, maintaining a robust balance sheet, and disciplined capital deployment amid ongoing uncertainty.
Exor N.V. Annual report: H2 2025
Exor N.V. has published its H2 2025 annual report on March 24, 2026.
Exor N.V. Slides: H2 2025
Exor N.V. has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.
Exor Swings to Net Loss as Listed Companies Hurt Results
The holding company of Italy's Agnelli family has suffered from poor performances at some of its largest listed companies, including Stellantis.
Exor to generate $2.3 billion from stake sales in Iveco, GEDI, Lifenet and NUO
Exor expects to rake in 2 billion euros ($2.32 billion) in proceeds this year from selling its stakes in four companies, the Agnelli family's investment firm said on Monday.
Exor Press Release - FY2025 Results
Amsterdam, 23 March 2026 EXOR REPORTS €37.1 BILLION GROSS ASSET VALUE AT END-2025 NAV per share decreased by 8.1% compared to a 5.4% increase in the MSCI World Index Performance was driven by challeng...
Exor, founder sell Italian private healthcare group Lifenet to insurer Reale Mutua
Exor , the Agnelli family's investment vehicle, and the founder of Lifenet Healthcare have agreed to sell the Italian private clinics and diagnostics group to insurer Reale Mutua, the companies said o...
Exor Press Release - 2026 Corporate Calendar
Amsterdam, 30 January 2026 EXOR PUBLISHES ITS 202 6 CORPORATE CALENDAR Exor N.V. announced today the following corporate calendar for 2026: 23 March 2026: Publication of the financial statements for t...
Exor-Ferrari Family Press Release - Shareholders' Agreement
Exor N.V., on the one hand, and Piero Ferrari and Trust Piero Ferrari, on the other hand, have agreed to renew the shareholders' agreement relating to Ferrari N.V., confirming their respective alignme...
Juventus stock jump after Exor rejects Tether's bid for Agnelli family stake
Juventus Football Club shares rose sharply after Exor, the Agnelli family's holding company, rejected an unsolicited takeover proposal from cryptocurrency issuer Tether, underscoring growing financial...
Exor Press Release - Announcement on Juventus
Amsterdam, 13 December 2025 EXOR BOARD UNANIMOUSLY REJECTS TETHER'S PROPOSAL TO ACQUIRE EXOR'S CONTROLLING STAKE IN JUVENTUS Exor N.V. (“Exor” or the “Company”) announces that its Board of Directors h...
Exor Press Release - Closing Announcement
Amsterdam, 5 November 2025 EXOR ANNOUNCES THE CLOSING OF ITS NOTES OFFERING Exor N.V. announces the settlement of the previously announced offering of €600 million notes priced on 29 October 2025 with...
Exor Press Release - Pricing Announcement
Amsterdam, 29 October 2025 EXOR ANNOUNCES THE PRICING OF €600 MILLION NOTES MATURING IN 2035 Exor N.V. (rated A– with a stable outlook by Standard & Poor's) announces that it has priced €600 million n...
Exor N.V. Earnings Call Transcript: H1 2025
NAV per share outperformed the MSCI World Index by 5%, driven by a €1 billion buyback and strong Lingotto performance. GAV decreased due to capital distributions, while Ferrari monetization and strategic investments enhanced flexibility.
Exor N.V. Quarterly report: H1 2025
Exor N.V. has published its H1 2025 quarterly earnings report on September 18, 2025.
Exor N.V. Slides: H1 2025
Exor N.V. has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 18, 2025.
Exor reports asset value drop, plans major investments after Iveco sale
The Agnelli family's financial arm Exor reported on Wednesday a fall in the value of its assets and confirmed it was looking to make "significant" new investments after the sale of bus and truck maker...
Exor Press Release - H1 2025 Results
Amsterdam, 17 September 2025 EXOR NAV PER SHARE OUTPERFORMS MSCI WORLD INDEX In the first half of 2025, Exor's net asset value (NAV) per share outperformed the MSCI World Index by 5 percentage points,...
Exor Press Release - 2025 AGM
Amsterdam, 22 May 2025 EXOR SHAREHOLDERS APPROVE ALL RESOLUTIONS AT AGM Exor N.V. (“Exor” or the “Company”) shareholders approved all resolutions proposed by the Board of Directors at the Annual Gener...